CEL-SCI Corporation (CVM) was a big mover last session, as the company saw its shares rise by almost 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Jan 21, as the stock is now up over 14% in the past one-month time frame.
Over the last 30 days, this biopharmaceutical company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
CEL-SCI Corp. currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked biomedical stock is AMAG Pharmaceuticals, Inc. (AMAG) with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment